Impax Laboratories (IPXL) Launches Generic Metadate CD

September 22, 2016 8:04 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Impax Laboratories, Inc. (Nasdaq: IPXL) announced the launch of a generic version of Metadate CD (methylphenidate hydrochloride extended-release capsules), 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg.

Impax is focused on further enhancing its portfolio of 73 solid oral dose and alternative dosage form generic products available. The launch of methylphenidate hydrochloride is Impax's sixth new product launch since the beginning of 2016.

Methylphenidate hydrochloride extended-release capsules had annual combined brand and generic sales of approximately $151 million in the United States, according to IMS Health (NSP) for the 12 months ending in July 2016.

For full Prescribing Information see https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bce4cf37-d6a3-4203-b45d-6d1c35510eec



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News

Add Your Comment